A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease. By Rebecca Robbins and Gina Kolata A ...
The construction industry overuses natural resources and energy, causing numerous environmental impacts (ENSHASSI; KOCHENDOERFER; RIZQ, 2014; MORA-BARRANTES et al., 2018; AKINTAYO et al., 2020). The ...
We report here a rare case of cutaneous infection due to Corynebacterium pseudodiphtheriticum. The patient presented to the clinical laboratory with a skin ulcer on his left leg. Gram-stained ...
On July 31, President Donald Trump signed an executive order that would bring the set of physical exercises back Christopher Rudolph is a contributing writer for PEOPLE. He previously covered ...
Add Futurism (opens in a new tab) Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. One of the industry’s ...
Sixto M. Leal Jr., M.D., Ph.D., Jay M. McDonald Endowed Professor in Experimental Pathology and Division Director, Laboratory Medicine, has been appointed to the American Board of Pathology's (ABPath) ...
In the ever-evolving landscape of pharmaceutical testing, ensuring the highest standards of microbial quality control (QC) is paramount. MicroQuant™, a cutting-edge solution from ATCC, is designed to ...
DENVER (KDVR) — Following a deadly E.coli outbreak tied to McDonald’s Quarter Pounders, the Colorado Department of Agriculture tested the chain’s beef patties for the bacteria. On Oct. 22, the ...
July 29 (Reuters) - Guardant Health (GH.O), opens new tab said its blood test to detect cancer that starts in the colon or rectum got an approval from the U.S. Food and Drug Administration, with the ...
Schools are required to test the progress of their English learners each year to determine whether they still need language instruction services or can exit out of such programs. In close to 40 states ...
European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission We conducted a retrospective cohort ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results